A machine learning model for predicting abnormal liver function induced by a Chinese herbal medicine preparation (Zhengqing Fengtongning) in patients with rheumatoid arthritis based on real-world study

被引:0
作者
Yu, Ze [1 ]
Kou, Fang [1 ]
Gao, Ya [2 ]
Gao, Fei [3 ]
Lyu, Chun-ming [4 ]
Wei, Hai [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai 201203, Peoples R China
[2] Fuwai Hosp, Chinese Acad Med Sci, Dept Pharm, Beijing 100037, Peoples R China
[3] Beijing Medicinovo Technol Co Ltd, Beijing 100071, Peoples R China
[4] Shanghai Univ Tradit Chinese Med, Expt Ctr Sci & Technol, Shanghai 201203, Peoples R China
来源
JOURNAL OF INTEGRATIVE MEDICINE-JIM | 2025年 / 23卷 / 01期
关键词
Rheumatoid arthritis; Medicine; Chinese traditional; Zhengqing Fengtongning; Abnormal liver function; Machine learning; Real world; SINOMENINE; RISK;
D O I
10.1016/j.joim.2024.12.001
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: Rheumatoid arthritis (RA) is a systemic autoimmune disease that affects the small joints of the whole body and degrades the patients' quality of life. Zhengqing Fengtongning (ZF) is a traditional Chinese medicine preparation used to treat RA. ZF may cause liver injury. In this study, we aimed to develop a prediction model for abnormal liver function caused by ZF. Methods: This retrospective study collected data from multiple centers from January 2018 to April 2023. Abnormal liver function was set as the target variable according to the alanine transaminase (ALT) level. Features were screened through univariate analysis and sequential forward selection for modeling. Ten machine learning and deep learning models were compared to find the model that most effectively predicted liver function from the available data. Results: This study included 1,913 eligible patients. The LightGBM model exhibited the best performance (accuracy = 0.96) out of the 10 learning models. The predictive metrics of the LightGBM model were as follows: precision = 0.99, recall rate = 0.97, F1_score = 0.98, area under the curve (AUC) = 0.98, sensitivity = 0.97 and specificity = 0.85 for predicting ALT < 40 U/L; precision = 0.60, recall rate = 0.83, F1_score = 0.70, AUC = 0.98, sensitivity = 0.83 and specificity = 0.97 for predicting 40 <= ALT < 80 U/L; and precision = 0.83, recall rate = 0.63, F1_score = 0.71, AUC = 0.97, sensitivity = 0.63 and specificity = 1.00 for predicting ALT >= 80 U/L. ZF-induced abnormal liver function was found to be associated with high total cholesterol and triglyceride levels, the combination of TNF-alpha inhibitors, JAK inhibitors, methotrexate + nonsteroidal anti-inflammatory drugs, leflunomide, smoking, older age, and females in middle-age (45-65 years old). Conclusion: This study developed a model for predicting ZF-induced abnormal liver function, which may help improve the safety of integrated administration of ZF and Western medicine. Please cite this article as: Yu Z, Kou F, Gao Y, Lyu CM, Gao F, Wei H. A machine learning model for predicting abnormal liver function induced by a Chinese herbal medicine preparation (Zhengqing Fengtongning) in patients with rheumatoid arthritis based on real-world study. J Integr Med. 2025; 23(1): 25-35. (c) 2024 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 45 条
[1]  
Aureal M., Machuca-Gayet I., Coury F., Rheumatoid arthritis in the view of osteoimmunology, Biomolecules, 11, 1, (2020)
[2]  
Ehrlich G.E., Kelley's textbook of rheumatology, JAMA, 302, 8, pp. 902-903, (2009)
[3]  
Tian X.P., Zeng X.F., Enhance treat-to-target strategy by standardize the diagnosis and treatment of rheumatoid arthritis, Zhonghua Nei Ke Za Zhi, 57, 4, pp. 240-241, (2018)
[4]  
Wei H.H., Zhao X.X., Cheng L., Li S.S., Song Y.L., Han T.F., Et al., Progress and the prospect of sinomenine to treat rheumatoid arthritis, Zhonghua Zhong Yi Yao Za Zhi, 28, 10, pp. 3001-3005, (2013)
[5]  
Li R.C., Li J., System review of Zhengqing Fengtongning and methotrexate on treatment of rheumatoid arthritis, Zhongguo Shi Yan Fang Ji Xue Za Zhi, 18, 11, pp. 1-4, (2012)
[6]  
Xu M., Liu L., Qi C., Deng B., Cai X., Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis, Planta Med, 74, 20, pp. 1423-1429, (2008)
[7]  
Teng P., Liu H.L., Zhang L., Feng L.L., Huai Y., Deng Z.S., Et al., Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents, Eur J Med Chem, 50, 12, pp. 63-74, (2012)
[8]  
Sun Y.C., Liu L.L., Shi T.L., Wang C.W., Zhang L., Su D., Et al., Retrospective analysis of gender differences in ADR of 7690 cases of reported adverse drug reactions, Anhui Yi Xue, 36, 4, pp. 436-440, (2015)
[9]  
Blonde L., Khunti K., Harris S.B., Meizinger C., Skolnik N.S., Interpretation and impact of real-world clinical data for the practicing clinician, Adv Ther, 35, 11, pp. 1763-1774, (2018)
[10]  
Palacios M., The quality of research with real-world evidence, Colomb Med (Cali), 50, 3, pp. 140-141, (2019)